[Guidelines for the epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults]

MeSH terms

• Adult
• Aged
• Ambulatory Care
• Anti-Bacterial Agents / therapeutic use*
• Community-Acquired Infections / diagnosis
• Community-Acquired Infections / drug therapy*
• Community-Acquired Infections / mortality
• Cross-Sectional Studies
• Drug Administration Schedule
• Drug Resistance, Bacterial
• Drug Therapy, Combination
• Evidence-Based Medicine
• Hospitalization
• Humans
• Intensive Care Units
• Pneumonia, Bacterial / diagnosis
• Pneumonia, Bacterial / drug therapy*
• Pneumonia, Bacterial / mortality
• Prognosis
• Pseudomonas Infections / diagnosis
• Pseudomonas Infections / drug therapy
• Pseudomonas Infections / mortality
• Pseudomonas aeruginosa
• Respiratory Tract Infections / diagnosis
• Respiratory Tract Infections / drug therapy*
• Respiratory Tract Infections / mortality
• Risk Factors
• Survival Rate